Pharmacological activation of Epac1, selective enhancement of Rap1/Rac1 signaling, or targeted suppression of RhoA/ROCK during the repair phase could accelerate endothelial sealing in acute inflammatory conditions such as sepsis, acute respiratory distress syndrome, and ischemia–reperfusion injury. The gene discussed is RHOA; the disease is acute respiratory distress syndrome.